Announcing the Launch of hyperCORE International
Super Network of highly awarded and experienced Clinical Research Site…
RESEARCH SPOTLIGHT: Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia
Centricity Research’s Chief Medical officer Dr. Ronnie Aronson shares…
RESEARCH SPOTLIGHT: Reproducibility in the cardiometabolic responses to high-intensity interval exercise in adults with type 1 diabetes
With one month of 2019 already completed, we are excited to share a 2nd FIT…
RESEARCH SPOTLIGHT: Optimal Insulin Correction Factor in Post–High-Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes: The FIT Study
On Monday November 19th, Centricity Research’s own Type 1 Diabetes &…
SCRS Webinar Spotlight - Stepping out of the box: Clinical Site Operations, Recruitment & Compliance
In May of 2018, Centricity Research's own Karri Venn (President, Research)…
Manuscript Accepted: SGLT2 inhibitors and incretin agents: associations with alanine aminotransferase activity in type 2 diabetes
LMC Healthcare & Centricity Researches own Drs. Ronnie Aronson, Harpreet…
Beyond Informed Consent — How To Better Engage Millennials (And Others) In Clinical Trials
Guest Columnists: Nazneen Qureshi, Manager, Patient Engagement, Centricity…
Industry News: Advancing Technologies and Creating Emerging Industry Standards
Sanofi: Accelerating Future Breakthroughs Through Clinical Trials:…
LMC|Manna Research will be at the 2018 World Vaccine Congress in Washington, D.C. – Will I be seeing you there?
LMC|Manna Research will be attending the 2018 World Vaccine Congress in in…
Does Your Clinical Trial Marketing Answer Patient Questions?
Nazneen Qureshi, manager of patient engagement at LMC|Manna Research and…